SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
__________________________________
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): August 24, 2005
__________
Elbit Medical Imaging Ltd.
(Exact name of registrant as specified in its charter)
Israel 000-28996 None
(State or other jurisdiction of (Commission file (I.R.S. employer
incorporation or organization) number) identification no.)
13 Mozes Street 67442
Tel Aviv, Israel (Zip code)
(Address of principal
executive offices)
Registrant's telephone number, including area code: 011 (972-3) 608-6010
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c)
Item 8.01. Other Events
------------
EMI Medical Imaging Ltd. (the "Registrant") is filing this current report
on Form 8-K in order to file a consent of one of its independent accountants to
the incorporation by reference of the report of such accountants with respect to
the Registrant's audited consolidated financial statements for the year ended
December 31, 2004 (the "2004 Financial Statements") in the registration
statement on Form S-8 (relating to the registration of shares to be used under
the Elbit Medical Imaging Ltd. 2001 Incentive Plan to Employees and Officers,
File Number 333-117509) filed by the Registrant prior to the date hereof. The
2004 Financial Statements were filed by the Registrant with the Securities and
Exchange Commission as part of its Annual Report on Form 20-F for the fiscal
year ended December 31, 2004.
Item 9.01 Financial Statements and Exhibits
---------------------------------
(c) Exhibits
Exhibit No. Description
----------- -----------
23.1 Consent of Mazars Paardekooper Hoffman
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, EMI Medical
Imaging Ltd. has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
Date: August 24, 2005
ELBIT MEDICAL IMAGING LTD.
By: /s/Shimon Yitzhaki
----------------------
Name: Shimon Yitzhaki
Title: President
Exhibit Index
Exhibit No. Description
----------- -----------
23.1 Consent of Mazars Paardekooper Hoffman